CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 55 filers reported holding CABALETTA BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,218,681 | +156.4% | 296,615 | +484.8% | 0.00% | – |
| Q1 2024 | $865,266 | -56.9% | 50,719 | -42.6% | 0.00% | -100.0% |
| Q4 2023 | $2,006,885 | +133.8% | 88,409 | -14.8% | 0.00% | – |
| Q1 2023 | $858,352 | +131.8% | 103,791 | +159.3% | 0.00% | – |
| Q4 2022 | $370,314 | +585.8% | 40,034 | -52.0% | 0.00% | – |
| Q3 2022 | $54,000 | +350.0% | 83,477 | +648.1% | 0.00% | – |
| Q2 2022 | $12,000 | -91.5% | 11,158 | -31.8% | 0.00% | – |
| Q2 2021 | $141,000 | -21.2% | 16,366 | +1.4% | 0.00% | – |
| Q1 2021 | $179,000 | – | 16,142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,825,976 | $26,140,278 | 22.61% |
| VR Adviser, LLC | 1,895,285 | $17,531,386 | 2.95% |
| CAXTON CORP | 84,728 | $783,735 | 2.00% |
| COMMODORE CAPITAL LP | 1,010,359 | $9,346 | 1.41% |
| BOONE CAPITAL MANAGEMENT LLC | 266,882 | $2,468,659 | 1.27% |
| Cormorant Asset Management, LP | 1,971,739 | $18,239 | 1.22% |
| TCG Crossover Management, LLC | 486,795 | $4,502,854 | 0.80% |
| Boxer Capital, LLC | 540,000 | $4,995,000 | 0.26% |
| Kynam Capital Management, LP | 165,486 | $1,530,746 | 0.24% |
| Eversept Partners, LP | 282,874 | $2,616,585 | 0.23% |